Alan Schwartz is a Respiratory physician. ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics need a complete publication history and a confident author match. We omit them when either check fails. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
- Home-Use Impact and Effectiveness of Cloud 9
Sponsor: Johns Hopkins University
- Targeted Hypoglossal Neurostimulation Study #3
Sponsor: ImThera Medical, Inc.
- The Sleep, Liver Evaluation and Effective Pressure Study
Sponsor: Johns Hopkins University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
42 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- LivaNova USA, Inc.Program year202552 payments$114,505openpaymentsdata.cms.gov ↗
- Itamar Medical IncProgram year20252 payments$84,284openpaymentsdata.cms.gov ↗
- Itamar MedicalProgram year20251 paymentResearch$29,596openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%gamma-Aminobutyric Acid A Receptor Positive Modulator100%Zolpidem Tartrate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
8 NIH research awards on record, funded 1988–2018 per NIH RePORTER. The latest:
- Treatment of sleep apnea by targeting leptin signaling
Johns Hopkins University
FY2018$519,348R01HL128970 - Postural therapy reduces sleep disordered breathing and cardiometabolic stress at altitude
Johns Hopkins University
FY2018$317,474R34HL135360 - Treatment of sleep apnea by targeting leptin signaling
Johns Hopkins University
FY2017$519,348R01HL128970
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Justin Oldham, MD
University of Michigan
Fernando Martinez, MD
University of Massachusetts Chan Medical School
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”